Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1319 Others
D03233 Acitazanolast hydrate (JAN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for ophthalmologic use
64 Allergy eye drops
D03233 Acitazanolast hydrate (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Acitazanolast
D03233 Acitazanolast hydrate (JAN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01805 Mediator release inhibitor
D03233 Acitazanolast hydrate
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03233
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03233
Rx-to-OTC switch list in Japan [br08314.html]
D03233
Other DBs
PubChem:
17397386
LigandBox:
D03233
KCF data
ATOM 18
1 C8x C 23.1800 -16.6533
2 C8y C 23.1800 -18.0578
3 C8x C 24.3963 -18.7601
4 C8y C 25.6127 -18.0578
5 C8x C 25.6127 -16.6533
6 C8x C 24.3963 -15.9510
7 C8y C 21.9637 -18.7601
8 N1b N 26.8542 -18.7601
9 C5a C 28.0706 -18.0578
10 C6a C 29.2870 -18.7601
11 O6a O 30.5033 -18.0578
12 O5a O 28.0706 -16.6535
13 O6a O 29.2870 -20.1646
14 N5x N 20.6269 -18.3434
15 N5x N 19.8182 -19.4862
16 N5x N 20.6551 -20.6085
17 N4x N 21.9811 -20.1593
18 O0 O 34.9780 -18.0578
BOND 18
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 4 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 9 12 2
13 10 13 2
14 7 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 7 17 1